Report cover image

Global Taurine and Derivatives Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Feb 07, 2025
Length 196 Pages
SKU # APRC20034052

Description

Summary

According to APO Research, the global Taurine and Derivatives market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Taurine and Derivatives is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Asia-Pacific market for Taurine and Derivatives is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Taurine and Derivatives market is expected to rise from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The Europe market for Taurine and Derivatives is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Taurine and Derivatives market include Taisho Pharmaceutical, Yuanyang Pharmaceutical, Jiangyin Huachang, Yongan Pharmaceutical, Zhejiang NHU Co., Ltd and Grand Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Taurine and Derivatives, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Taurine and Derivatives, also provides the sales of main regions and countries. Of the upcoming market potential for Taurine and Derivatives, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Taurine and Derivatives sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Taurine and Derivatives market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Taurine and Derivatives sales, projected growth trends, production technology, application and end-user industry.

Taurine and Derivatives Segment by Company

Taisho Pharmaceutical
Yuanyang Pharmaceutical
Jiangyin Huachang
Yongan Pharmaceutical
Zhejiang NHU Co., Ltd
Grand Pharma
Taurine and Derivatives Segment by Type

Taurine
Taurine Derivatives
Taurine and Derivatives Segment by Application

Beverages
Pet Food
Health Products
Others
Taurine and Derivatives Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Taurine and Derivatives status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Taurine and Derivatives market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Taurine and Derivatives significant trends, drivers, influence factors in global and regions.
6. To analyze Taurine and Derivatives competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Taurine and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Taurine and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Taurine and Derivatives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Taurine and Derivatives market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Taurine and Derivatives industry.
Chapter 3: Detailed analysis of Taurine and Derivatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Taurine and Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Taurine and Derivatives in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

196 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Taurine and Derivatives Sales Value (2020-2031)
1.2.2 Global Taurine and Derivatives Sales Volume (2020-2031)
1.2.3 Global Taurine and Derivatives Sales Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Taurine and Derivatives Market Dynamics
2.1 Taurine and Derivatives Industry Trends
2.2 Taurine and Derivatives Industry Drivers
2.3 Taurine and Derivatives Industry Opportunities and Challenges
2.4 Taurine and Derivatives Industry Restraints
3 Taurine and Derivatives Market by Company
3.1 Global Taurine and Derivatives Company Revenue Ranking in 2024
3.2 Global Taurine and Derivatives Revenue by Company (2020-2025)
3.3 Global Taurine and Derivatives Sales Volume by Company (2020-2025)
3.4 Global Taurine and Derivatives Average Price by Company (2020-2025)
3.5 Global Taurine and Derivatives Company Ranking (2023-2025)
3.6 Global Taurine and Derivatives Company Manufacturing Base and Headquarters
3.7 Global Taurine and Derivatives Company Product Type and Application
3.8 Global Taurine and Derivatives Company Establishment Date
3.9 Market Competitive Analysis
3.9.1 Global Taurine and Derivatives Market Concentration Ratio (CR5 and HHI)
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.9.3 2024 Taurine and Derivatives Tier 1, Tier 2, and Tier 3 Companies
3.10 Mergers and Acquisitions Expansion
4 Taurine and Derivatives Market by Type
4.1 Taurine and Derivatives Type Introduction
4.1.1 Taurine
4.1.2 Taurine Derivatives
4.2 Global Taurine and Derivatives Sales Volume by Type
4.2.1 Global Taurine and Derivatives Sales Volume by Type (2020 VS 2024 VS 2031)
4.2.2 Global Taurine and Derivatives Sales Volume by Type (2020-2031)
4.2.3 Global Taurine and Derivatives Sales Volume Share by Type (2020-2031)
4.3 Global Taurine and Derivatives Sales Value by Type
4.3.1 Global Taurine and Derivatives Sales Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Taurine and Derivatives Sales Value by Type (2020-2031)
4.3.3 Global Taurine and Derivatives Sales Value Share by Type (2020-2031)
5 Taurine and Derivatives Market by Application
5.1 Taurine and Derivatives Application Introduction
5.1.1 Beverages
5.1.2 Pet Food
5.1.3 Health Products
5.1.4 Others
5.2 Global Taurine and Derivatives Sales Volume by Application
5.2.1 Global Taurine and Derivatives Sales Volume by Application (2020 VS 2024 VS 2031)
5.2.2 Global Taurine and Derivatives Sales Volume by Application (2020-2031)
5.2.3 Global Taurine and Derivatives Sales Volume Share by Application (2020-2031)
5.3 Global Taurine and Derivatives Sales Value by Application
5.3.1 Global Taurine and Derivatives Sales Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Taurine and Derivatives Sales Value by Application (2020-2031)
5.3.3 Global Taurine and Derivatives Sales Value Share by Application (2020-2031)
6 Taurine and Derivatives Regional Sales and Value Analysis
6.1 Global Taurine and Derivatives Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Taurine and Derivatives Sales by Region (2020-2031)
6.2.1 Global Taurine and Derivatives Sales by Region: 2020-2025
6.2.2 Global Taurine and Derivatives Sales by Region (2026-2031)
6.3 Global Taurine and Derivatives Sales Value by Region: 2020 VS 2024 VS 2031
6.4 Global Taurine and Derivatives Sales Value by Region (2020-2031)
6.4.1 Global Taurine and Derivatives Sales Value by Region: 2020-2025
6.4.2 Global Taurine and Derivatives Sales Value by Region (2026-2031)
6.5 Global Taurine and Derivatives Market Price Analysis by Region (2020-2025)
6.6 North America
6.6.1 North America Taurine and Derivatives Sales Value (2020-2031)
6.6.2 North America Taurine and Derivatives Sales Value Share by Country, 2024 VS 2031
6.7 Europe
6.7.1 Europe Taurine and Derivatives Sales Value (2020-2031)
6.7.2 Europe Taurine and Derivatives Sales Value Share by Country, 2024 VS 2031
6.8 Asia-Pacific
6.8.1 Asia-Pacific Taurine and Derivatives Sales Value (2020-2031)
6.8.2 Asia-Pacific Taurine and Derivatives Sales Value Share by Country, 2024 VS 2031
6.9 South America
6.9.1 South America Taurine and Derivatives Sales Value (2020-2031)
6.9.2 South America Taurine and Derivatives Sales Value Share by Country, 2024 VS 2031
6.10 Middle East & Africa
6.10.1 Middle East & Africa Taurine and Derivatives Sales Value (2020-2031)
6.10.2 Middle East & Africa Taurine and Derivatives Sales Value Share by Country, 2024 VS 2031
7 Taurine and Derivatives Country-level Sales and Value Analysis
7.1 Global Taurine and Derivatives Sales by Country: 2020 VS 2024 VS 2031
7.2 Global Taurine and Derivatives Sales Value by Country: 2020 VS 2024 VS 2031
7.3 Global Taurine and Derivatives Sales by Country (2020-2031)
7.3.1 Global Taurine and Derivatives Sales by Country (2020-2025)
7.3.2 Global Taurine and Derivatives Sales by Country (2026-2031)
7.4 Global Taurine and Derivatives Sales Value by Country (2020-2031)
7.4.1 Global Taurine and Derivatives Sales Value by Country (2020-2025)
7.4.2 Global Taurine and Derivatives Sales Value by Country (2026-2031)
7.5 USA
7.5.1 USA Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.5.2 USA Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.5.3 USA Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.6 Canada
7.6.1 Canada Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.6.2 Canada Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.6.3 Canada Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.7 Mexico
7.6.1 Mexico Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.6.2 Mexico Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.6.3 Mexico Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.8 Germany
7.8.1 Germany Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.8.2 Germany Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.8.3 Germany Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.9 France
7.9.1 France Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.9.2 France Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.9.3 France Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.10 U.K.
7.10.1 U.K. Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.10.2 U.K. Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.10.3 U.K. Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.11 Italy
7.11.1 Italy Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.11.2 Italy Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.11.3 Italy Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.12 Spain
7.12.1 Spain Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.12.2 Spain Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.12.3 Spain Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.13 Russia
7.13.1 Russia Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.13.2 Russia Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.13.3 Russia Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.14 Netherlands
7.14.1 Netherlands Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.14.2 Netherlands Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.14.3 Netherlands Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.15 Nordic Countries
7.15.1 Nordic Countries Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.15.2 Nordic Countries Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.15.3 Nordic Countries Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.16 China
7.16.1 China Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.16.2 China Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.16.3 China Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.17 Japan
7.17.1 Japan Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.17.2 Japan Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.17.3 Japan Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.18 South Korea
7.18.1 South Korea Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.18.2 South Korea Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.18.3 South Korea Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.19 India
7.19.1 India Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.19.2 India Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.19.3 India Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.20 Australia
7.20.1 Australia Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.20.2 Australia Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.20.3 Australia Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.21 Southeast Asia
7.21.1 Southeast Asia Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.21.2 Southeast Asia Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.21.3 Southeast Asia Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.22 Brazil
7.22.1 Brazil Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.22.2 Brazil Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.22.3 Brazil Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.23 Argentina
7.23.1 Argentina Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.23.2 Argentina Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.23.3 Argentina Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.24 Chile
7.24.1 Chile Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.24.2 Chile Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.24.3 Chile Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.25 Colombia
7.25.1 Colombia Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.25.2 Colombia Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.25.3 Colombia Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.26 Peru
7.26.1 Peru Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.26.2 Peru Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.26.3 Peru Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.27 Saudi Arabia
7.27.1 Saudi Arabia Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.27.2 Saudi Arabia Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.27.3 Saudi Arabia Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.28 Israel
7.28.1 Israel Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.28.2 Israel Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.28.3 Israel Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.29 UAE
7.29.1 UAE Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.29.2 UAE Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.29.3 UAE Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.30 Turkey
7.30.1 Turkey Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.30.2 Turkey Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.30.3 Turkey Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.31 Iran
7.31.1 Iran Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.31.2 Iran Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.31.3 Iran Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
7.32 Egypt
7.32.1 Egypt Taurine and Derivatives Sales Value Growth Rate (2020-2031)
7.32.2 Egypt Taurine and Derivatives Sales Value Share by Type, 2024 VS 2031
7.32.3 Egypt Taurine and Derivatives Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Taisho Pharmaceutical
8.1.1 Taisho Pharmaceutical Comapny Information
8.1.2 Taisho Pharmaceutical Business Overview
8.1.3 Taisho Pharmaceutical Taurine and Derivatives Sales, Value and Gross Margin (2020-2025)
8.1.4 Taisho Pharmaceutical Taurine and Derivatives Product Portfolio
8.1.5 Taisho Pharmaceutical Recent Developments
8.2 Yuanyang Pharmaceutical
8.2.1 Yuanyang Pharmaceutical Comapny Information
8.2.2 Yuanyang Pharmaceutical Business Overview
8.2.3 Yuanyang Pharmaceutical Taurine and Derivatives Sales, Value and Gross Margin (2020-2025)
8.2.4 Yuanyang Pharmaceutical Taurine and Derivatives Product Portfolio
8.2.5 Yuanyang Pharmaceutical Recent Developments
8.3 Jiangyin Huachang
8.3.1 Jiangyin Huachang Comapny Information
8.3.2 Jiangyin Huachang Business Overview
8.3.3 Jiangyin Huachang Taurine and Derivatives Sales, Value and Gross Margin (2020-2025)
8.3.4 Jiangyin Huachang Taurine and Derivatives Product Portfolio
8.3.5 Jiangyin Huachang Recent Developments
8.4 Yongan Pharmaceutical
8.4.1 Yongan Pharmaceutical Comapny Information
8.4.2 Yongan Pharmaceutical Business Overview
8.4.3 Yongan Pharmaceutical Taurine and Derivatives Sales, Value and Gross Margin (2020-2025)
8.4.4 Yongan Pharmaceutical Taurine and Derivatives Product Portfolio
8.4.5 Yongan Pharmaceutical Recent Developments
8.5 Zhejiang NHU Co., Ltd
8.5.1 Zhejiang NHU Co., Ltd Comapny Information
8.5.2 Zhejiang NHU Co., Ltd Business Overview
8.5.3 Zhejiang NHU Co., Ltd Taurine and Derivatives Sales, Value and Gross Margin (2020-2025)
8.5.4 Zhejiang NHU Co., Ltd Taurine and Derivatives Product Portfolio
8.5.5 Zhejiang NHU Co., Ltd Recent Developments
8.6 Grand Pharma
8.6.1 Grand Pharma Comapny Information
8.6.2 Grand Pharma Business Overview
8.6.3 Grand Pharma Taurine and Derivatives Sales, Value and Gross Margin (2020-2025)
8.6.4 Grand Pharma Taurine and Derivatives Product Portfolio
8.6.5 Grand Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Taurine and Derivatives Value Chain Analysis
9.1.1 Taurine and Derivatives Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Taurine and Derivatives Sales Mode & Process
9.2 Taurine and Derivatives Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Taurine and Derivatives Distributors
9.2.3 Taurine and Derivatives Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.